French Company RDS Gets €14 Million for Patient Monitoring

In this article, you’ll discover:

  • How French company RDS raised an impressive €14 million, nearly doubling its initial target.
  • A closer look at MultiSense®, the smart wearable patch and cloud system changing patient monitoring.
  • The key features that make the patch patient-friendly, including its light weight and 5-day battery life.
  • The company’s clear plan for the funds, from growing their team to launching a 400+ patient study.
  • Their ambitious goal to enter the US market, including plans for FDA submission.

Have you ever been in a hospital or seen a movie where a patient is hooked up to a bunch of machines with wires everywhere? It looks uncomfortable, and all the beeping can be a lot to handle. A company in France is working to change that, and they just got a huge vote of confidence.

RDS, a medical technology company, just announced they raised €14 million in funding. What’s really interesting is that they were only planning to raise between €6 and €8 million. When investors give a company almost double what it asked for, it means they believe something special is happening. For RDS, that “something special” is a tiny device that could change how doctors look after their patients.

What is RDS and MultiSense®?

Based in Strasbourg, France, RDS is a company on a mission to improve “patient pathways.” In simple terms, they want to make the experience of getting medical care smoother and better for everyone involved. Their main product is called MultiSense®, and it’s a pretty clever system.

Think of it like a high-tech health tracker, but for medical use. It has two main parts:

  1. A small, wearable patch that sticks to your body.
  2. A secure cloud platform where doctors and nurses can see your health information in real-time.

The goal is to let doctors continuously monitor a patient’s health without needing bulky equipment, whether they are in a hospital bed or recovering at home.

A Tiny Patch with Big Power

RDS - Advancing Patient Pathways. Brings to Life the Next Generation of Patient Monitoring Solution.

The real star of the show is the MultiSense® Patch. This isn’t some big, clunky device. It’s a lightweight patch that weighs only 25 grams, which is about the same as a few coins in your pocket.

Instead of being placed on the chest, it goes on the upper back, which makes it more comfortable and less in the way. It’s also water-resistant, so patients can take a normal shower without having to take it off. That’s a small detail that makes a big difference in feeling normal.

The patch is packed with five different sensors that track a patient’s heart rate, breathing, oxygen levels, skin temperature, and even their posture. It can do this for five full days on a single charge, sending all that important data to the doctors.

So, What’s the Money For?

Raising €14 million is a huge achievement, and RDS has a clear plan for how to use it. They are not just sitting on the cash; they are putting it to work to grow their company and its impact.

First, they plan to expand their sales and support teams to meet the growing demand in Europe. They are also scaling up their manufacturing in France, which helps keep production of this important medical gear closer to home.

A large chunk of the funds will go toward a health study with over 400 patients. The study aims to prove that using MultiSense® can help patients have shorter hospital stays after surgery. If they can prove that, it would be a massive win for both patients and hospitals.

And for those of us in the United States, here’s the big news: RDS is preparing for FDA submission. Their goal is to bring MultiSense® to the US market by 2028.

Why This Matters

This technology isn’t just about cool gadgets; it’s about making healthcare better and more human. For patients, it could mean more freedom of movement, less stress from noisy machines, and the peace of mind that comes from being monitored safely, even from home.

For doctors and nurses, it means having a constant, clear view of a patient’s condition on a simple dashboard. They can even set up custom notifications to alert them if something changes. This helps them catch problems early and focus their time on the patients who need it most.

It’s exciting to see a company like RDS get the funding it needs to grow. Their simple idea of a smart patch could have a huge impact, making hospital stays less stressful and recovery a little bit easier. We’ll be watching to see what they do next.

Similar Posts

  • How QoreAI Helps Car Dealers Fix Messy Data

    Car dealerships use too many software tools that do not share information. QoreAI solves this problem by keeping all dealership data in one clean place. With the help of the Lokam.ai voice bot, dealers can now improve customer service, get better reviews, and close more car sales easily…

  • Hippocratic AI Raises $126 Million for AI Health Agents

    Hippocratic AI just raised a huge $126 million to grow its AI health agents. Their entire focus is on safety, earning trust from major hospitals and handling over 115 million patient interactions with zero safety issues…

  • Unlearn Launches TrialPioneer to Help Clinical Teams Plan Better

    Unlearn has introduced TrialPioneer, a new AI workspace for clinical trial planning. It helps teams align on design choices by bringing evidence and simulations into one place. This tool aims to make decision-making faster and reduce rework later in the process…

  • Integration Health Unites Specialized Services on One Platform

    Life-saving tech like ECMO is often too complex for many hospitals to manage. Integration Health just launched a platform to fix this, acting as a single partner to solve the access problem and help hospitals save more lives. Here’s how they’re doing it…